← Leaderboards
Khalid Islam
Biological Anti-Infective Medicines, Llc
$3,122,415
Attributed
$3,122,415
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2016–18$2M$1.5M$1M$500K$0
'16
'17
'18
Funding mix
By agency
NIH$3,122,415 · 1
By mechanism
R42$3,122,415 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Acinetobacter Baumannii”
- Jian Li · Monash University$18,286,971
- Brad J Spellberg · La Biomed Res Inst/ Harbor Ucla Med Ctr$14,243,117
- Helen I. Zgurskaya · University Of Oklahoma Norman$11,559,071
- David S Perlin · Hackensack University Medical Center$11,429,593
- Scott J Hultgren · Washington University$11,102,102
- Jurgen Bernd Bulitta · State University Of New York At Buffalo$10,686,622
Research focus
Acinetobacter BaumanniiAnti-Bacterial AgentsAntibiotic ResistanceAcinetobacter InfectionsAntibodiesAspiration PneumoniaBacteriaBacterial ResistanceAntibioticsBindingBlood CirculationCell BankCessation Of LifeCommercializationContractsCostDesignDeveloped CountriesBaseDrug ResistanceExtensive Drug ResistanceFundingFutureGrant
Grant awards (3)
Humanized Monoclonal Antibody to Treat Acinetobacter Infections$1,070,000
R42 · FY2018 · AI · contact PI
Humanized Monoclonal Antibody to Treat Acinetobacter Infections$1,070,000
R42 · FY2017 · AI · contact PI
Humanized Monoclonal Antibody to Treat Acinetobacter Infections$982,415
R42 · FY2016 · AI · contact PI